Gene therapy

MRI of the brain
#epilepsy #Gene therapy #Mouse models #Preclinical investigations #University College London

Gene therapy could reduce seizures in childhood epilepsy

University College London (UCL) researchers have developed a new gene therapy to cure focal cortical dysplasia, which a new study shows can significantly reduce seizures in mice. Focal cortical dysplasia is caused by areas of the brain that have developed abnormally and is among the most… Read More

#Editor's Choice #News

The European Medicines Agency building
#CHMP #EU #European Medicines Agency #Gene therapy #Regulatory

New drug recommendations by the EU’s CHMP

The European Medicines Agency (EMA) human medicines committee (CHMP) made a number of key recommendations at its December 2023 meeting. Casgevy The committee recommended granting a conditional marketing authorisation for Casgevy (exagamglogene autotemcel), an advanced therapy medicinal product (ATMP) for the treatment of transfusion dependent beta-thalassemia and severe sickle cell… Read More

#News #Regulatory #Trending News

#Advanced Therapies #CAR-T #Cell and gene therapy #Cell therapy #Drug discovery #eBook #Gene therapy

DDW eBook: The latest innovations in cell and gene therapy

Hailed as a revolution in the treatment of many diseases, cell and gene therapy is the fastest growing area of therapeutics. This eBook, ‘Cell & Gene Therapy: The advances and innovation’, provides a comprehensive overview of the latest innovations in cell and gene therapies, where the… Read More

#News

#Advanced Therapies #CAR-T #Cell and gene therapy #Cell therapy #Drug discovery #eBook #Gene therapy

Cell & Gene Therapy: The advances and innovation

This 24-page eBook sponsored by Sartorius explores the latest innovations in cell and gene therapies, where the challenges lie and the possible solutions to overcoming these obstacles. Download this free resource to learn more about: The ways cell and gene therapies (CGTs) are revolutionising medicine in a range of diseases How… Read More

#DDW eBooks #Intelligence

#CAR-T #Cell and gene therapy #Cell therapy #CRISPR #Drug discovery #Gene therapy

New DDW Highlights podcast: 20 November 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The breaking news this week was certainly the first regulatory approval for… Read More

#News

#CAR-T #Cell and gene therapy #Cell therapy #CRISPR #Drug discovery #Gene therapy

This week in drug discovery (13-17 November) 

News round-up for 13-17 November by DDW Digital Content Editor Diana Spencer. The breaking news this week was certainly the first regulatory approval for Casgevy, not only the first gene therapy approved for sickle cell disease, but also the first therapy to use CRISPR gene editing. Read More

#News

Heart monitor
#Asklepios BioPharmaceutical #Cardiovascular disease #Gene therapy #Heart failure #Phase I trial

One-time gene therapy could change treatment of heart failure

Asklepios BioPharmaceutical (AskBio), a gene therapy subsidiary of Bayer, has presented first-in-human data from a Phase I trial investigating AB-1002 (also known as NAN-101) for the treatment of patients with congestive heart failure (CHF). The data were shared at the American Heart Association Scientific Sessions, which… Read More

#Editor's Choice #News

CRISPR gene editing
#CRISPR #CRISPR Therapeutics #Gene therapy #MHRA #Sickle cell disorder (SCD) #Vertex

Great Britain first to approve CRISPR-based gene therapy

The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised the world’s first gene therapy for sickle-cell disease (SCD) and transfusion-dependent β-thalassemia (TDT). Casgevy (exagamglogene autotemcel, or exa-cel) is the first medicine to be licensed that uses gene editing tool CRISPR, for which its inventors were awarded the Nobel Prize… Read More

#News #Regulatory #Trending News

Hematopoietic cells
#Cancer research #Clinical trial #Gene therapy #MHRA #Paediatrics #Phase I trial #Stem cells #UK

First gene therapy trial for Hunter syndrome opens in Manchester, UK

UK regulatory authorities have approved the first trial of a gene therapy for young children with Hunter syndrome. The UK Medicines and Healthcare Products Regulatory Agency (MHRA), Research Ethics Committee (REC), and Health Research Authority (HRA) have all approved the clinical trial application that was submitted by The University of… Read More

#Editor's Choice #News #Regulatory

Organ-on-a-chip
#Cancer research #Emulate #Gene therapy #Organ-on-a-chip #Preclinical investigations

Are organ-chips the future of preclinical research?

Listen to this article on the DDW Podcast: Diana Spencer catches up with Lorna Ewart, PhD, Chief Scientific Officer of Emulate, about the rise of organ-on-a-chip technology. Organ-chips combine cell culture with microfluidics to emulate the biological forces of different organ tissues and/or disease states, allowing pharmaceutical researchers to determine a… Read More

#Exclusive Content

#Drug development #Drug discovery #Gene therapy #Genetics / genomics #mRNA

New DDW Highlights podcast: 10 October 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  In celebration of the Nobel Prize for Medicine going to two of… Read More

#News

Non-small cell lung cancer
#Gene therapy #Lung cancer #Non-small cell lung cancer (NSCLC) #Oncology #Phase I trial

Non-viral gene therapy shows early efficacy in lung cancer

Positive Phase I trial data indicates that Reqorsa (quaratusugene ozeplasmid) has shown early efficacy for the treatment of non-small cell lung cancer (NSCLC). The data will be presented at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. Developed by… Read More

#Cancer Research #News

#Drug development #Drug discovery #Gene therapy #Genetics / genomics #mRNA

This week in drug discovery (2-6 October)  

News round-up for 2-6 October by DDW Digital Content Editor Diana Spencer. In celebration of the Nobel Prize for Medicine going to two of the early proponents of mRNA technology for creating therapeutics, Katalin Karikó and Drew Weissman, this week our round-up highlights the importance of… Read More

#News

Doctor points at child's brain scan
#Francis Crick Institute #Gene therapy #Great Ormond Street Hospital #Paediatrics #Rare disease

Researchers design genetic therapy to prevent brain deterioration

A research team at the Francis Crick Institute and Great Ormond Street Hospital (GOSH)/UCL Great Ormond Street Institute of Child Health have identified potential treatments for children with rare genetic conditions. The researchers have shown that problems with calcium underlie these progressive diseases. Stabilising calcium levels… Read More

#Editor's Choice #News

Adenovirus
#AAV #Azenta Life Sciences #Gene delivery #Gene therapy #Webinar

Guide to using AAV vectors in gene therapy

Earlier this year, DDW hosted a webinar, 'A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy', supported by Azenta Life Sciences. The event aimed to help the audience understand the AAV workflow, from upstream methods for AAV production and validation to downstream analysis of the packaged product… Read More

#Exclusive Content

Cell and gene therapies
#Advanced Therapies #Advanced Therapies Europe #Cell and gene therapy #Cell therapy #Gene therapy

Advanced Therapies Europe: From bench to bedside and boardroom

Advanced Therapies Europe took place from 9-12 September 2023 in Portugal. DDW’s Megan Thomas asked attendees: What is most important to scale from discovery to commercialisation of cell and gene therapies (CGTs)? Joel Eichmann, Co-Founder, Green Elephant Biotech It always comes down to time-to-market and risk minimisation. To cover these,… Read More

#Exclusive Content